Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Headache, Migraine: later-stage trial registry

2 of 8 indexed Headache, Migraine trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Headache, Migraine: 8 US clinical trials tracked, 2 recruiting.

Headache, Migraine is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Click Therapeutics, running 2 of these trials.

Enrollment posture brief

Registry condition headache-migraine

OPEN 2 | RECR 25% | LATE 3 | EARLY 1 | RANK #2176 | SPON 2

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Headache, Migraine (this)25%
Open-enrollment share among volume-matched conditions near Headache, Migraine

Headache, Migraine lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Headache, Migraine on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Headache, Migraine is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Headache, Migraine research.

    Click Therapeutics accounts for 2 of 8 trials (25%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Headache, Migraine enrolment sits around 174 participants.

    Median target enrolment is 174 among the 8 trials that report a genuine target (sentinel values excluded). 2 of those (25%) plan for fewer than 100 participants.

  4. Headache, Migraine research is mostly interventional.

    8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 32Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 2
Phase 4 1

Named interventions

Most-linked intervention names on Headache, Migraine records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Click Digital Therapeutic Device
1 trials
Ethynil Estradiol/Norgestimate Oral Contraceptive Drug
1 trials
Tx360 Device
1 trials
ReMMi-D Digital Therapeutic Device
1 trials
Erenumab Drug
1 trials
Holographic Memory Resolution® (HMR) Behavioral
1 trials
Ubrogepant 100 MG [Ubrelvy] Drug
1 trials
Ubrogepant 50 MG [Ubrelvy] Drug
1 trials

US sites by state

Facility locations filed on Headache, Migraine trials. A trial with sites in several states counts in each.

New York 4 trials
Texas 3 trials
Pennsylvania 2 trials
Ohio 2 trials
Louisiana 2 trials
Georgia 2 trials
Colorado 2 trials
California 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Headache, Migraine page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Headache, Migraine condition card totals 8 registered trials; most-linked intervention Click Digital Therapeutic; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.